pharmaceuticals
pharmaceuticals Articles
24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest of 2018.
Published:
Last Updated:
Tesaro shares absolutely exploded early on Monday after the company announced that it has entered a definitive agreement to be acquired by GlaxoSmithKline.
Published:
Last Updated:
Tonix Pharmaceuticals shares were up sharply on Thursday after the company announced an update from the FDA.
Published:
Last Updated:
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Catabasis Pharmaceuticals shares made a handy gain on Tuesday after the company announced early stage data from its Duchenne muscular dystrophy study.
Published:
Last Updated:
Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study.
Published:
Last Updated:
Mallinckrodt has been a prominent player in the health care industry and while most analysts are taking a middle-of-the-road approach to the company, one has come out with a very bullish report.
Published:
Last Updated:
Here 24/7 Wall St. takes a look at a recent report by Canaccord Genuity regarding to biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest...
Published:
Last Updated:
Biopharmaceutical company Synthorx has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Published:
Last Updated:
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
Published:
Last Updated:
Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination regimens in multiple cancer settings.
Published:
Last Updated:
Eli Lilly released better-than-expected third-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Eli Lilly is scheduled to release its most recent quarterly results before the markets open on Tuesday.
Published:
Last Updated:
Teva Pharmaceutical released its most recent earnings report before the markets opened on Thursday.
Published:
Last Updated: